ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Perioperative Blood Transfusion is Associated with the Development of New HLA Antibodies After Adult Lung Transplantation

    A. Hicks1, A. Stoker2, M. Cooter2, A. Ali3, J. Klapper4, J. Poisson5, D. Chen5, J. Haney4, K. Ghadimi2, M. Hartwig4, I. Welsby2, B. Bottiger2

    1Anesthesiology, Duke University Hospital, South Portland, ME, 2Anesthesiology, Duke University Hospital, Durham, NC, 3Pulmonology, Allergy and Critical Care Medicine, Duke University Hospital, Durham, NC, 4Cardiothoracic Surgery, Duke University Hospital, Durham, NC, 5Pathology, Duke University Hospital, Durham, NC

    *Purpose: Lung transplant (LT) recipients who develop new antibodies to human leukocyte antigen (HLA) have associated with chronic lung allograft dysfunction and worsened outcomes. We…
  • 2021 American Transplant Congress

    A Patient-Centered Perspective on Progress in Transplantation

    B. Hickner1, N. Galvan2, R. Cotton2, C. O'Mahony2, J. Goss2, A. Rana2

    1Department of Student Affairs, Baylor College of Medicine, Houston, TX, 2Department of Surgery, Baylor College of Medicine, Houston, TX

    *Purpose: This study aimed to provide a patient-centered perspective on change in transplantation outcomes through analysis of intent-to-treat survival, which accounted for donor shortages by…
  • 2021 American Transplant Congress

    Desensitization Using Costimulatory Blockade and Bortezomib to Prevent DSA Formation and Rejection in Reconstructive Transplantation

    B. Oh1, F. Messner2, Y. Guo1, G. Brandacher1

    1Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Visceral, Transplant and Thoracic Surgery, University of Innsbruck, Innsbruck, Austria

    *Purpose: Sensitization in form of donor-specific antibodies (DSA) and subsequent antibody-mediated rejection constitute some of the greatest risk factors for allograft rejection and long-term graft…
  • 2021 American Transplant Congress

    Utility of Screening-Bead Assay in Post-Transplant Testing of Donor-Specific Antibodies (DSA) and Antibody-mediated Rejection (ABMR) in Renal Allografts

    A. Agrawal1, E. Dijke2, A. Murray3, P. Campbell3

    1Transplant Nephrology, Mayo Clinic, Rochester, MN, 2Lab. Medicine and Pathology, University of Alberta Hospital, Edmonton, AB, Canada, 3Division of Nephrology, Dept. of Medicine, University of Alberta Hospital, Edmonton, AB, Canada

    *Purpose: ABMR is a major cause of poor long-term graft survival. Though post-transplant monitoring of HLA DSAs can aid in risk stratification and optimizing immunosuppression,…
  • 2021 American Transplant Congress

    Liver Kinase B1 Knockdown Induces Platelet-Derived Growth Factor Receptor B Expression in Human Airway Epithelial Cells: A Potential Mechanism for Development of Fibrosis Leading to Chronic Lung Allograft Dysfunction

    M. Rahman, J. Lee, R. Ravichandran, T. Fleming, M. Smith, R. Bremner, T. Mohanakumar

    St. Joseph’s Hospital and Medical Center, Phoenix, AZ

    *Purpose: The platelet-derived growth factor and its receptor (PDGFRb) signaling pathway can be activated by epithelial mesenchymal transition which facilitates fibrosis. It is not known…
  • 2021 American Transplant Congress

    Characterizing the Early Impact of the Kidney Accelerated Placement Project on Hard-to-place Kidneys

    J. D. Motter, A. Kernodle, M. Levan, D. Segev, J. Garonzik-Wang, A. Massie

    Johns Hopkins University, Baltimore, MD

    *Purpose: In 2019, the OPTN implemented the Kidney Accelerated Placement Project (KAPP) in an effort to increase the utilization of kidneys with a high Kidney…
  • 2021 American Transplant Congress

    Donor-Recipient BSA Matching is Prognostically Significant in Solitary and En-bloc Kidney Transplantation from Pediatric Circulatory Death Donors

    C. J. Little, A. A. Dick, J. D. Perkins, J. D. Reyes

    Department of Surgery, University of Washington, Seattle, WA

    *Purpose: The purpose of this study was to evaluate the pernicious effects of inadequate functional nephron mass in size disparate donation after cardiac death (DCD)…
  • 2021 American Transplant Congress

    Can Procurement Biopsy Data Tell Us Anything? The Influence of Glomerulosclerosis on Long-term Kidney Graft Survival

    D. Stewart1, L. Kamal2, J. Foutz3, H. McGehee3, P. Saravanane2, S. Yu2, R. Yousfi2, G. Gupta2

    1United Network for Organ Sharing, Richmond, VA, 2Virginia Commonwealth University Health, Richmond, VA, 3Research, United Network for Organ Sharing, Richmond, VA

    *Purpose: Biopsy findings, particularly % glomerulosclerosis, have been shown to have a profound impact on kidney utilization decisions. Most studies of the association between procurement…
  • 2021 American Transplant Congress

    Centers Avoided 67% of Kidney Offers by Participating in the OPTN’s Multifactorial Offer Filter Pilot Project

    A. Toll, H. McGehee, D. Stewart, R. McTier

    Research, United Network for Organ Sharing, Richmond, VA

    *Purpose: Evaluate if multifactorial filters can reduce unwanted kidney offers to centers, thereby reducing administrative burden and getting to the accepting candidate quicker.*Methods: 40 centers…
  • 2021 American Transplant Congress

    Outcomes of Downstaging Hepatocellular Carcinoma (HCC) to within Milan Criteria Before Liver Transplantation (LT): A Multicenter Analysis of the “All-comers” Protocol

    B. Natarajan1, P. Tabrizian2, M. Hoteit3, C. Frenette4, T. Ghaziani5, R. Dhanasekaran5, N. Parikh6, J. Guy7, A. Shui1, S. Florman2, F. Yao1, N. Mehta1

    1UCSF, SF, CA, 2Mt Sinai, NY, NY, 3U Penn, Philadelphia, PA, 4Scripps, La Jolla, CA, 5Stanford, Palo Alto, CA, 6U Michigan, Ann Arbor, MI, 7CPMC, SF, CA

    *Purpose: Patients with HCC meeting UNOS-downstaging (DS) criteria (1 lesion 5.1-8 cm, 2-3 lesions at least one 3.1-5 cm and total tumor diameter (TTD) ≤8…
  • « Previous Page
  • 1
  • …
  • 232
  • 233
  • 234
  • 235
  • 236
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences